GeneDx Holdings Corp.
$66.85
(as of Apr 30, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Ticker Information for GeneDx Holdings Corp.
Stock Price
$66.85
Ticker Symbol
WGS
Exchange
NASDAQ
Industry Information for GeneDx Holdings Corp.
Sector
Healthcare
Industry
Diagnostics & Research
Company Description for GeneDx Holdings Corp.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company is headquartered in Stamford, Connecticut.
Fundamentals for GeneDx Holdings Corp.
Market Capitalization
$3,209,519,616
EBITDA
$-408,000
Dividends per Share
P/E Ratio
Forward P/E Ratio
0
Earnings per Share
$-1.93
Earnings per Share Estimate Next Year
Profit Margin
-17.12%
Shares Outstanding
28,531,600
Percent Owned by Insiders
12.70%
Percent Owned by Institutions
86.50%
52-Week High
52-Week Low
Technical Indicators for GeneDx Holdings Corp.
Analyst Ratings for GeneDx Holdings Corp.
Strong Buy
3
Buy
0
Hold
3
Sell
0
Strong Sell
0
News About GeneDx Holdings Corp.
May 1, 2025, 3:09 AM EST
Revenue: $87.1 million for Q1 2025. See more.
May 1, 2025, 1:00 AM EST
Participants
See more.
Apr 30, 2025, 4:29 PM EST
Investors hammered GeneDx stock on Wednesday after the diagnostics company beat first-quarter expectations — but not by enough.
See more.
Apr 30, 2025, 12:28 PM EST
Key Points
See more.